NASDAQ : IMMX
Immix Biopharma, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 7.98 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 661.57M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 20.19M | 13.70M | 11.38M | 7.41M | 4.02M | 1.23M |
| Research & Development | 21.62M | 16.26M | 11.29M | 8.74M | 4.20M | 126.53K |
| Operating Expenses | 41.82M | 29.96M | 22.67M | 16.14M | 8.22M | 1.35M |
| Operating Income | -41.82M | -29.96M | -22.67M | -16.14M | -8.22M | -1.35M |
| Interest Expense | -497.00 | -179.85K | ||||
| Interest & Investment Income | 1.93M | 555.53K | 1.02M | 572.01K | ||
| Other Non Operating Income (Expenses) | -22.76M | |||||
| EBT Excluding Unusual Items | -39.88M | -29.40M | -21.66M | -15.57M | -8.22M | -24.29M |
| Other Unusual Items | -86.17K | |||||
| Pretax Income | -39.88M | -29.40M | -21.66M | -15.57M | -8.22M | -24.38M |
| Income Tax Expense | 33.31K | 37.72K | 41.04K | 26.41K | 10.27K | 6.01K |
| Earnings From Continuing Operations | -39.92M | -29.44M | -21.70M | -15.60M | -8.23M | -24.38M |
| Minority Interest in Earnings | 84.99K | 169.47K | ||||
| Net Income | -39.92M | -29.44M | -21.61M | -15.43M | -8.23M | -24.38M |
| Net Income to Common | -39.92M | -29.44M | -21.61M | -15.43M | -8.23M | -24.38M |
| Shares Outstanding (Basic) | 47.84M | 32.97M | 28.29M | 17.34M | 13.89M | 3.67M |
| Shares Outstanding (Diluted) | 47.84M | 32.97M | 28.29M | 17.34M | 13.89M | 3.67M |
| EPS (Basic) | -0.83 | -0.89 | -0.76 | -0.89 | -0.59 | -6.64 |
| EPS (Diluted) | -0.83 | -0.89 | -0.76 | -0.89 | -0.59 | -6.64 |
| Free Cash Flow | -39.09M | -24.66M | -15.77M | -11.42M | -7.41M | -1.59M |
| Free Cash Flow Per Share | -0.82 | -0.75 | -0.56 | -0.66 | -0.53 | -0.43 |
| EBITDA | -41.48M | -29.71M | -22.64M | -16.14M | -8.22M | -1.35M |
| D&A For EBITDA | 331.67K | 245.75K | 32.94K | 5.47K | 2.13K | 2.47K |
| EBIT | -41.82M | -29.96M | -22.67M | -16.14M | -8.22M | -1.35M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 225.49M | 93.93M | 17.68M | 17.51M | 13.44M | 17.64M |
| Short-Term Investments | 6.62M | 6.48M | ||||
| Cash & Short-Term Investments | 232.11M | 100.41M | 17.68M | 17.51M | 13.44M | 17.64M |
| Other Receivables | 1.97M | 1.17M | 255.71K | 25.72K | ||
| Receivables | 1.97M | 1.17M | 255.71K | 25.72K | ||
| Prepaid Expenses | 1.40M | 677.61K | 509.24K | 1.06M | 1.13M | 516.19K |
| Other Current Assets | 279.17K | 150.72K | 32.27K | 44.58K | 78.07K | |
| Total Current Assets | 233.79M | 101.24M | 20.20M | 19.79M | 14.90M | 18.19M |
| Property, Plant & Equipment | 3.25M | 3.49M | 2.73M | 50.18K | 3.56K | 5.70K |
| Long-Term Deferred Charges | 93.63K | 87.23K | 6.72K | |||
| Other Long-Term Assets | 20.42K | 20.42K | 20.42K | |||
| Total Assets | 239.11M | 104.84M | 22.95M | 19.93M | 14.91M | 18.19M |
| Accounts Payable | 5.28M | 5.44M | 5.39M | 1.43M | 143.07K | 142.94K |
| Accrued Expenses | 3.91M | 4.53M | 3.23M | 2.29M | 1.13M | 9.10K |
| Short-Term Debt | 50.00K | |||||
| Current Portion of Leases | 111.11K | 139.34K | 65.22K | |||
| Total Current Liabilities | 9.30M | 10.11M | 8.69M | 3.72M | 1.27M | 202.04K |
| Long-Term Leases | 890.64K | 933.62K | 1.01M | |||
| Other Long-Term Liabilities | 475.00K | |||||
| Total Liabilities | 10.19M | 11.04M | 9.70M | 3.72M | 1.75M | 202.04K |
| Common Stock | 7.16K | 5.30K | 2.76K | 2.00K | 1.40K | 1.32K |
| Additional Paid-In Capital | 355.00M | 198.29M | 88.37M | 69.78M | 51.16M | 47.62M |
| Retained Earnings | -126.11M | -104.46M | -75.02M | -53.41M | -37.99M | -29.76M |
| Treasury Stock | -99.96K | -99.96K | -99.96K | -99.96K | -99.96K | |
| Comprehensive Income & Other | 118.72K | 60.16K | -1.06K | 134.67K | 87.02K | 125.41K |
| Total Common Equity | 228.92M | 93.80M | 13.25M | 16.41M | 13.16M | 17.99M |
| Minority Interest | -201.74K | |||||
| Shareholders' Equity | 228.92M | 93.80M | 13.25M | 16.20M | 13.16M | 17.99M |
| Total Liabilities & Equity | 239.11M | 104.84M | 22.95M | 19.93M | 14.91M | 18.19M |
| Total Debt | 1.00M | 1.07M | 1.07M | 50.00K | ||
| Net Cash (Debt) | 231.11M | 99.34M | 16.61M | 17.51M | 13.44M | 17.59M |
| Net Cash Per Share | 4.83 | 3.01 | 0.59 | 1.01 | 0.97 | 4.79 |
| Filing Date Shares Outstanding | 71.54M | 52.96M | 27.72M | 26.40M | 13.90M | 13.86M |
| Total Common Shares Outstanding | 71.54M | 52.95M | 27.54M | 19.92M | 13.89M | 13.23M |
| Working Capital | 224.49M | 91.13M | 11.51M | 16.07M | 13.62M | 17.98M |
| Book Value Per Share | 3.20 | 1.77 | 0.48 | 0.82 | 0.95 | 1.36 |
| Tangible Book Value | 228.92M | 93.80M | 13.25M | 16.41M | 13.16M | 17.99M |
| Tangible Book Value Per Share | 3.20 | 1.77 | 0.48 | 0.82 | 0.95 | 1.36 |
| Machinery | 1.59M | 1.57M | 848.64K | 64.50K | ||
| Construction In Progress | 938.77K | |||||
| Leasehold Improvements | 1.24M | 1.24M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -39.92M | -29.44M | -21.61M | -15.43M | -8.23M | -24.38M |
| Depreciation & Amortization | 487.14K | 364.50K | 115.39K | 5.47K | 2.13K | 2.47K |
| Other Amortization | 58.16K | |||||
| Stock-Based Compensation | 2.59M | 2.44M | 3.02M | 2.57M | 624.07K | 218.98K |
| Other Operating Activities | -84.99K | -169.47K | 22.91M | |||
| Change in Accounts Payable | -549.17K | 1.03M | 4.40M | 2.43M | 1.13M | -106.06K |
| Change in Income Taxes | 33.94K | 2.06M | -971.53K | -893.40K | -236.38K | 97.67K |
| Change in Other Net Operating Assets | -1.13M | -384.74K | 537.20K | 111.84K | -700.15K | -382.64K |
| Operating Cash Flow | -38.50M | -23.93M | -14.60M | -11.37M | -7.41M | -1.59M |
| Capital Expenditures | -591.11K | -732.92K | -1.18M | -52.09K | -802.00 | |
| Investment in Securities | -8.56M | -6.48M | ||||
| Investing Cash Flow | -9.15M | -7.21M | -1.18M | -52.09K | -802.00 | |
| Long-Term Debt Issued | 200.00K | |||||
| Total Debt Issued | 200.00K | |||||
| Short-Term Debt Repaid | -50.00K | |||||
| Total Debt Repaid | -50.00K | |||||
| Net Debt Issued (Repaid) | -50.00K | 200.00K | ||||
| Issuance of Common Stock | 261.66M | 107.52M | 15.95M | 15.52M | 2.91M | 18.65M |
| Repurchase of Common Stock | -99.96K | |||||
| Other Financing Activities | -137.00K | -137.00K | -59.62K | 468.28K | ||
| Financing Cash Flow | 261.52M | 107.39M | 15.95M | 15.46M | 3.23M | 18.85M |
| Foreign Exchange Rate Adjustments | -20.45K | 3.84K | -3.62K | 33.09K | -31.52K | -5.43K |
| Net Cash Flow | 213.85M | 76.25M | 172.16K | 4.07M | -4.21M | 17.25M |
| Free Cash Flow | -39.09M | -24.66M | -15.77M | -11.42M | -7.41M | -1.59M |
| Free Cash Flow Per Share | -0.82 | -0.75 | -0.56 | -0.66 | -0.53 | -0.43 |
| Levered Free Cash Flow | -25.39M | -13.61M | -7.55M | -5.94M | -4.31M | -2.10M |
| Unlevered Free Cash Flow | -25.39M | -13.61M | -7.55M | -5.94M | -4.31M | -2.04M |
| Cash Interest Paid | 9.60K | 1.54K | ||||
| Change in Working Capital | -1.65M | 2.70M | 3.97M | 1.65M | 195.21K | -391.04K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 636.69M | 275.60M | 60.52M | 137.48M | 31.89M | 47.02M |
| Enterprise Value | 405.59M | 260.76M | 41.92M | 117.77M | 14.98M | 51.23M |
| Last Close Price | 7.68 | 5.23 | 2.20 | 6.92 | 2.29 | 3.56 |
| PB Ratio | 2.40 | 2.94 | 4.57 | 8.48 | 2.42 | 2.61 |
| P/TBV Ratio | 2.78 | 2.94 | 4.57 | 8.38 | 2.42 | 2.61 |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.08 | 0.00 | ||
| Net Debt / Equity Ratio | -1.01 | -1.06 | -1.25 | -1.08 | -1.02 | -0.98 |
| Net Debt / EBITDA Ratio | 5.57 | 3.34 | 0.73 | 1.08 | 1.64 | 13.04 |
| Net Debt / FCF Ratio | 5.91 | 4.03 | 1.05 | 1.53 | 1.81 | 11.06 |
| Quick Ratio | 24.95 | 9.93 | 2.26 | 5.02 | 10.75 | 87.46 |
| Current Ratio | 25.13 | 10.01 | 2.33 | 5.32 | 11.70 | 90.01 |
| Return on Equity (ROE) | -34.18% | -55.00% | -147.33% | -106.22% | -52.84% | -367.80% |
| Return on Assets (ROA) | -20.52% | -29.30% | -66.11% | -57.92% | -31.04% | -9.02% |
| Return on Capital Employed (ROCE) | -18.20% | -31.60% | -159.00% | -99.60% | -60.30% | -7.50% |
| Earnings Yield | -10.86% | -10.68% | -35.72% | -11.22% | -25.80% | -51.85% |
| FCF Yield | -6.14% | -8.95% | -26.06% | -8.31% | -23.23% | -3.38% |
| Buyback Yield / Dilution | -61.22% | -16.55% | -63.11% | -24.87% | -278.13% | -8.82% |